What is Bristol-Myers Squibb's proceeds from other short-term debt?

Bristol-Myers Squibb (BMY) reported proceeds from other short-term debt of $321.00M in Q1 2026.

How has Bristol-Myers Squibb's proceeds from other short-term debt changed year-over-year?

Bristol-Myers Squibb's proceeds from other short-term debt decreased by 12.8% year-over-year, from $368.00M to $321.00M.

Financing

Proceeds from Other Short-Term Debt

Bristol-Myers Squibb Proceeds from Other Short-Term Debt increased by 6320.0% to $321.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.8%, from $368.00M to $321.00M.

Analysis

StatementCash Flow Statement

SectionFinancing

First reportedQ1 2022

Last reportedQ1 2026Apr 30, 2026

Metric ID: t_proceeds_other_short_term_debt

Historical Data

12 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$48.50M	$48.50M	$48.50M	$48.50M	-$353.00M	$83.00M	$326.00M	$95.00M	$368.00M	$58.00M	$5.00M	$321.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	-827.8%	+123.5%	+292.8%	-70.9%	+287.4%	-84.2%	-91.4%	>999%
YoY Change	—	—	—	—	-827.8%	—	—	—	+343.4%	-82.2%	-94.7%	-12.8%

Range-$353.00M – $368.00M

CAGR+98.8%

Avg YoY Growth-134.8%

Median YoY Growth-82.2%

Frequently Asked Questions

What is Bristol-Myers Squibb's proceeds from other short-term debt?: Bristol-Myers Squibb (BMY) reported proceeds from other short-term debt of $321.00M in Q1 2026.
How has Bristol-Myers Squibb's proceeds from other short-term debt changed year-over-year?: Bristol-Myers Squibb's proceeds from other short-term debt decreased by 12.8% year-over-year, from $368.00M to $321.00M.